5
Views
7
CrossRef citations to date
0
Altmetric
Original Article

Isolation and partial characterization of a glycine-and serine-rich polypeptide from human serum high-density lipoproteins (HDL)

, &
Pages 749-755 | Received 10 Jun 1977, Accepted 26 Aug 1977, Published online: 08 Jul 2009
 

Abstract

Lately, several minor polypeptides characterized by a high content of glycine and serine have been described in human serum lipoproteins. By column chromatography we have isolated a glycine- and serine-rich polypeptide from totally delipidized high-density lipoproteins, apo-HDL. The partial characterization of this polypeptide by total amino acid composition and by immunology utilizing monospecific antisera to polypeptides of human serum lipoproteins, would indicate a unique polypeptide. This low molecular weight (4900 Daltons) glycine- and serine-rich polypeptide was characterized by a mobility on poly-acrylamide gel electrophoresis, similar to that of polypeptide A-I, a blocked NH2-terminal amino acid and a terminal COOH-fragment consisting of R-Ser-Ala-Gly-Gly. There are similarities between this polypeptide and the protein moiety of a cholesterol ester-rich lipoprotein fraction, HDLsup, obtained by in vitro incubation of HDL subtractions and described in earlier publications by our group. The identity between these two polypeptides, however, cannot be confirmed by the present study.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.